Photo of Bishal Gyawali from oncology.queensu.ca
Aug 23, 2023, 17:23
Bishal Gyawali: When a new trial is published or presented, the first thing you do should not be tweet “congratulations” at the author…
Bishal Gyawali, an Associate Professor at the Division of Cancer Care and Epidemiology at Queen’s University, Kingston, Canada, wrote on Twitter/X.
“Don’t know who needs to hear this but when a new trial is published or presented, the first thing you do should not be tweet “congratulations“ at the author or say “great news for the patients”. The first thing you do should be to actually read the paper and decide whether you agree with the choice of control arm or the trial methods.”
Source: Bishal Gyawali/Twitter
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 30, 2025, 18:52
Mar 30, 2025, 18:31